Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 258

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 258
---
 Exchange Act, and includes shares of our Common Stock with respect to which the Selling Securityholder have voting and investment power. The percentage of Common Stock beneficially owned by the Selling Securityholder prior to the offering shown in the table below is based on an aggregate of 1,194,802 shares of our Common Stock outstanding on June 30, 2025. Because the purchase price of the Common Stock issuable under the Keystone Purchase Agreements is determined on each Fixed Purchase Date, with respect to a Fixed Purchase, on the applicable VWAP Purchase Date, with respect to a VWAP Purchase, and on the applicable Additional VWAP Purchase Date, with respect to an Additional VWAP Purchase, the number of shares that may actually be sold by us to the Selling Securityholder under the Keystone Purchase Agreements may be more or fewer than the number of shares being offered by this prospectus. We may amend or supplement this prospectus from time to time in the future to update or change the Selling Securityholder list and the securities that may be resold. 147 Please see the section titled “ Plan of Distribution” for further information regarding the Selling Securityholder’s method of distributing these securities.

|                                    |     | Common Stock       
 Beneficially Owned |        |     | Maximum Number      
 of Common Stock     
 to be Offered       
 Pursuant to         |            |     | Common           
 Stock Owned      
 After this       
 Offering (1) (2) |            |     |             |      |   |
| Name of Selling Securityholder     |     | Prior to this      
 Offering (1) (2)   |        |     | this Prospectus (2) |            |     | Number of        
 Shares           |            |     | Percent (3) |      |   |
| Keystone Capital Partners, LLC (4) |     |                    | 62,751 |     |                     | 12,500,000 |     |                  | 12,562,751 |     |             | 4.99 | % |

| (1) | Beneficial ownership as reflected in this table reflects the total number of shares potentially issuable underlying the Preferred               
 Shares and Warrants, and does not give effect to the various limitations on the conversion of the Preferred Shares and exercise of the          
 Warrants. Accordingly, actual beneficial ownership, as calculated in accordance with Section 13(d) and Rule 13d-3 thereunder may be lower       
 than as reflected in the table. The number of shares of Common Stock beneficially owned